Volumetric assessment of myocardial viability in rats using 3D double contrast enhanced T1 and T2-weighted MRI

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 18, Issue 6, 2005, Pages 302-308

  Chapon, C ^a,b   Franconi, F ^b   Lemaire, L ^a,b   Marescaux, L ^c   Legras, P ^d   Denizot, B ^a   Le Jeune, J J ^a  

^a INSERM   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c LUNAM UNIVERSITÉ   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

3D MRI; Contrast agents; Myocardial infarction; Rat; Viability

Indexed keywords

CONTRAST MEDIUM; GADOTERATE MEGLUMINE; GADOTERIC ACID; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOUBLE CONTRAST RADIOGRAPHY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART VOLUME; IN VIVO STUDY; INJECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; THREE DIMENSIONAL IMAGING; VOLUMETRY;

ANALYSIS OF VARIANCE; ANIMALS; CONTRAST MEDIA; HETEROCYCLIC COMPOUNDS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; NANOTECHNOLOGY; ORGANOMETALLIC COMPOUNDS; PARTICLE SIZE; RATS;

ANIMALIA;

EID: 31544456671     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-005-0016-9     Document Type: Article

References (20)

1. Gersh BJ, Anderson JL (1993) Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm-paradoxic or predictable? Circulation 88:296-306
2. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM (2000) Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 102:1678-1683
3. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765-772
4. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB (2001) Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 103:871-876
5. Barkhausen J, Ebert W, Debatin JF, Weinmann HJ (2002) Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits. J Am Coll Cardiol 39(8): 1392-1398
6. Chapon C, Lemaire L, Franconi F, Marescaux L, Legras P, Denizot B, Le Jeune JJ (2004) Assessment of myocardial viability in rats: evaluation of a new method using superparamagnetic iron oxide nanoparticles and Gd-DOTA at high magnetic field. Magn Reson Med 52:932-936
7. Alley MT, Napel S, Amano Y, Paik DS, Shifrin RY, Shimakawa A, Pelc NJ, Herfkens RJ (1999) Fast 3D cardiac cine MR imaging. J Magn Reson Imaging 9:751-755
8. Dumoulin CL, Souza SP, Darrow RD, Adams WJ (1991) A method of coronary MR angiography. J Comput Assist Tomogr 15:705-710
9. Duerinckx AJ (1997) MRI of coronary arteries. Int J Card Imaging 13:191-197
10. Hofman MB, Paschal CB, Li D, Haacke EM, van Rossum AC, Sprenger M (1995) MRI of coronary arteries: 2D breath-hold vs 3D respiratory-gated acquisition. J Comput Assist Tomogr 19:56-62
11. Ruff J, Wiesmann F, Lanz T, Haase A (2000 ) Magnetic resonance imaging of coronary arteries and heart valves in a living mouse: techniques and preliminary results. J Magn Reson 146:290-296
12. Hockings PD, Roberts T, Galloway GJ, Reid DG, Harris DA, Vidgeon-Hart M, Groot PH, Suckling KE, Benson GM (2002) Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation 106:1716-1721
13. Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P (1991) Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging 9:275-283
14. Messager T, Franconi F, De Bray JM, Denizot B, Lemaire L, Jallet P, Le Jeune JJ (1999) Contrast agents relaxivities evolution with magnetic field strength (0.47 to 7 T). MAGMA 8.
15. Selye H, Bajusz E, Grasso S, Mendell P (1960) Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11:398-407
16. Chapon C, Franconi F, Lemaire L, Marescaux L, Legras P, Saint-André JP, Denizot B, Le Jeune JJ (2003) High field MR Imaging evaluation of superparamagnetic iron oxide nanoparticles in a permanent rat myocardial infarction. Invest Radiol 38(3):141-146
17. Bjerner T, Wikstrom G, Johansson L, Ahlstrom H (2004) High in-plane resolution T2- weighted magnetic resonance imaging of acute myocardial ischemia in pigs using the intravascular contrast agent NC100150 injection. Invest Radiol 39(8):470-478
18. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB (1977) The wavefront phenomenon of ischemic cell death, 1: myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56:786-794
19. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM (2001) Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104(10):1101-1107
20. 1 H magnetic resonance imaging. Magn Reson Mater Phy 16:129-134